Standard Biotools Inc (LAB)
Standard Biotools stock today
Standard Biotools closed at $0.61 on October 30, 2026, down 1.61% on the day. Over the past year it returned -47.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $238 million.
| Period | LAB | S&P 500 (SPY) |
|---|---|---|
| 1 month | -17.6% | -0.9% |
| 3 months | -32.0% | +2.1% |
| Year to date | -52.3% | +11.7% |
| 1 year | -47.0% | +12.4% |
| 3 years | -68.4% | +88.5% |
Key statistics
- Market value
- $238M
- P/E (trailing)
- 2.8
- Price / sales
- 2.8
- 52-week range
- $0.60 to $1.68
- Next report
- Nov 3, 2026 (estimated)
About Standard Biotools
Develops life sciences instruments and consumables for research and diagnostics.
Sector: Health Care
More on Standard Biotools
- Financials: revenue, earnings and segmentsRevenue -6% in the year to Dec 2025
- Valuation: P/E history and peersP/E 2.8
- Returns: what $1,000 became$1,000 three years ago is $316.06 today
No forecast, no recommendation. This page describes Standard Biotools Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.